Literature DB >> 32043445

Modifications in a Reference Freeze-Dried Direct Agglutination Test to Improve Visceral Leishmaniasis Detection.

Abdallah El Harith1, Yousif Awad1, Abdelhafeiz Mahamoud1, Elfadil Abass2, Durria Mansour3, Claudia Moura de Melo4, Rubens Riscala Madi4, Saul J Semiao-Santos5, Hussam Ali Osman1.   

Abstract

Currently, a significantly lower temperature (35°C) than initially established (56°C) is indicated as the maximum temperature storage for the commercial reference visceral leishmaniasis (VL) freeze-dried direct agglutination test (FD-DAT). Despite an approximately 50% loss in the number of promastigotes in an FD-DAT batch that expired 7 years earlier, the promastigotes maintained a similar morphology to the equivalent valid batch implying most likely that auto-agglutination, rather than aging, is the main reason for expiry. The substitution of normal saline which was initially recommended for reconstitution, by citrate-saline/formaldehyde (CSF) as an anti-clumping/preservative agent resulted in restoration of validity comparable with that of the freeze-dried original or the liquid direct agglutination test (LQ-DAT) version (Friedman ANOVA test = 1.0588; P = 0.5890). Following a similar reconstitution procedure as for the 7-year expired antigen, using significantly lower promastigote concentration (1.4 × 107/mL) than in the non-expired (9.0 × 107/mL), good reliability for VL detection and stability at 4°C (> 12 months) were achieved. In comparison with the original version using normal saline ($32.0/vial), the cost-effectiveness of the FD-DAT was appreciably improved by the CSF incorporation and lowering of promastigote concentration per unit suspension medium ($12.8/vial). With diagnostic reliability comparable with the full-out titration used, FD-DAT procedure based on single sample dilution at the VL cutoff (1:3,200) permitted the use of significantly smaller antigen volumes (0.1 mL vs. > 1.5 mL), therefore contributing to a further reduction in the application cost. The successful replacement of β-mercaptoethanol (β-ME) by urea (T = 21.00; P = 0.0868) provided the required safety for the test procedure similar to the widely applied LQ-DAT.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32043445      PMCID: PMC7124908          DOI: 10.4269/ajtmh.19-0745

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  19 in total

1.  Evaluation of the direct agglutination test based on freeze-dried Leishmania donovani promastigotes for the serodiagnosis of visceral leishmaniasis in Sudanese patients.

Authors:  Khalid A A Abdallah; Bakri Y M Nour; Henk D F H Schallig; Adil Mergani; Zohal Hamid; Abdallah Abd Elkarim; Osman K Saeed; Ahmed A Mohamadani
Journal:  Trop Med Int Health       Date:  2004-10       Impact factor: 2.622

2.  Identification of an area predominantly endemic for childhood and adolescent visceral leishmaniasis in central Sudan.

Authors:  Abdelhafeiz Mahamoud; Hussam Ali Osman; Elfadil Mustafa Abass; Atif El Agib; Rubens Riscala Madi; Saul J Semiao-Santos; Abdallah El Harith
Journal:  Acta Trop       Date:  2017-11-26       Impact factor: 3.112

3.  The direct agglutination test for diagnosis of visceral leishmaniasis under field conditions in Sudan: comparison of aqueous and freeze-dried antigens.

Authors:  E E Zijlstra; O F Osman; H W Hofland; L Oskam; H W Ghalib; A M el-Hassan; P A Kager; S E Meredith
Journal:  Trans R Soc Trop Med Hyg       Date:  1997 Nov-Dec       Impact factor: 2.184

4.  Toxicological studies of 2-mercaptoethanol.

Authors:  K White; J V Bruckner; W L Guess
Journal:  J Pharm Sci       Date:  1973-02       Impact factor: 3.534

5.  Evaluation of a newly developed direct agglutination test (DAT) for serodiagnosis and sero-epidemiological studies of visceral leishmaniasis: comparison with IFAT and ELISA.

Authors:  A E Harith; A H Kolk; P A Kager; J Leeuwenburg; F J Faber; R Muigai; S Kiugu; J J Laarman
Journal:  Trans R Soc Trop Med Hyg       Date:  1987       Impact factor: 2.184

6.  User and environment friendly direct agglutination test for the sero-diagnosis of visceral leishmaniasis: exclusion of formaldehyde and β-mercaptoethanol in test execution.

Authors:  Abdelhafeiz Mahamoud; Yousif Awad; Hussam Ali Osman; Atif El Agib; Rubens Riscala Madi; Saul J Semiao-Santos; Abdallah El Harith
Journal:  J Med Microbiol       Date:  2018-10-16       Impact factor: 2.472

7.  Evaluation of cleaving agents other than trypsin in direct agglutination test for further improving diagnosis of visceral leishmaniasis.

Authors:  A el Harith; S Chowdhury; A al-Masum; S Semião-Santos; E Karim; S el-Safi; I Haque
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

8.  A killing disease epidemic among displaced Sudanese population identified as visceral leishmaniasis.

Authors:  P de Beer; A el Harith; L L Deng; S J Semiao-Santos; B Chantal; M van Grootheest
Journal:  Am J Trop Med Hyg       Date:  1991-03       Impact factor: 2.345

9.  Sero-epidemiological assessment and diagnosis of visceral leishmaniasis in an endemic locality using Fast Agglutination Screening Test (FAST).

Authors:  A Hailu; C C M Kroon; G J Schoone; N Berhe; H D F H Schallig; P A Kager
Journal:  Acta Trop       Date:  2002-08       Impact factor: 3.112

Review 10.  Are We Now Well Prepared for Another Major Visceral Leishmaniasis Epidemic in Sudan?

Authors:  Abdallah El Harith; Abdelhafeiz Mahamoud; Yousif Awad; Durria Mansour; Elfadil Mustafa Abass; Atif El Agib; Rubens Riscala Madi; Saul J Semiao-Santos; Hussam Ali Osman
Journal:  Open Forum Infect Dis       Date:  2019-05-15       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.